SA
ZBH icon

Seneschal Advisors’s Zimmer Biomet ZBH Stock Holding History

Seneschal Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$259 Sell
3
-1
-25% -$88 ﹤0.01% 514
2026
Q1 		$362 Buy
4
+1
+33% +$92 ﹤0.01% 435
2025
Q4 		$270 Sell
3
-1
-25% -$95 ﹤0.01% 486
2025
Q3 		$394 Buy
+4
New +$396 ﹤0.01% 428

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Seneschal Advisors's ZBH Position: Q2 2026 in Review

Seneschal Advisors reduced its Zimmer Biomet (ZBH) stake by 25% in Q2 2026, selling an estimated $88 and leaving 3 shares worth $259. The position accounts for ﹤0.01% of the portfolio, ranked #514.

Seneschal Advisors first reported a position in ZBH in Q3 2025 and has held it in 4 quarters since. The position peaked at $394 in Q3 2025. 909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Seneschal Advisors held 3 shares of Zimmer Biomet worth $259 as of Q2 2026.
  • Seneschal Advisors sold 1 Zimmer Biomet share in Q2 2026, an estimated $88.
  • Zimmer Biomet made up ﹤0.01% of Seneschal Advisors's portfolio in Q2 2026, its #514 holding.
  • Seneschal Advisors first reported a position in Zimmer Biomet in Q3 2025 and has held it in 4 quarters since.
  • Seneschal Advisors's Zimmer Biomet position peaked at $394 in Q3 2025.
  • 909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Seneschal Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.